• United Nations
    Amidst a Global Pandemic, Another Shameful WHO Vote on Israel
    Here we are in the middle of a global pandemic, but the WHO’s annual meeting can still abandon its responsibilities and divert into an assault on Israel. This is what happened on Wednesday, May 26, at the WHO’s annual meeting. It was not at all surprising that a group of Arab countries and various dictatorships—the Palestinian resolution was cosponsored by countries such as Cuba, Iraq, Libya, Pakistan, Qatar, Saudi Arabia, Sudan, Syria, Turkey, Venezuela and Yemen—introduced a resolution rebuking Israel. Needless to say, this being the WHO there was no such rebuke for countries that did not achieve Israel’s remarkable success in vaccinating its population (which, it seems necessary to add, is twenty percent Arab). The resolution requires yet another time-wasting debate at next year’s annual meeting as well. Not surprising. What is surprising is the vote. This contemptible resolution was supported by France, Spain, Switzerland, Belgium, Portugal, Japan, India, Ireland, New Zealand, Luxembourg, and 72 other countries, UN Watch reports.  There is some good news: it was opposed by United States, Britain, Australia, Austria, Brazil Cameroon, Canada, Colombia, Czech Republic, Germany, Honduras, Hungary, and the Netherlands. The vote was 82 in favor, 14 opposed, and a very large bloc abstaining (40) or absent (38). That means that 82 countries were in favor and 92 were not. The vote that those European democracies plus New Zealand and Japan cast is a foul politicization of the WHO—at a moment when its handling of the Covid pandemic and of China is very much in question. And it guarantees politicization again next year, wasting ever more time. One may hope that parliamentarians in those countries will raise questions about the decision to completely misrepresent Israel’s Covid record and further damage the WHO. What the diplomats and politicians in those governments thought would be gained is never clear. They must know they are harming the WHO, and they should know that such gestures will never satisfy those in their countries whose real goal is eliminating Israel, not rebuking it in a vote in Geneva. The United Nations is supposedly going to lead the effort to assist Gazans while preventing any of that aid from assisting Hamas. One wonders if those who voted for this resolution ever stop to wonder how such actions affect Israelis’ confidence in the UN system’s ability to do its work reliably, honestly, and courageously in the teeth of a terrorist group that will seek to intimidate it. Or perhaps one doesn’t need to wonder very much.  Even during a global pandemic, it seems they do not wonder or they do not care.
  • Global Governance
    The State of Global Governance in the Era of COVID-19: A Conversation With Richard Haass and the Council of Councils
    Play
    Richard N. Haass, Chen Dongxiao, and Nathalie Tocci discuss the mounting challenges to global governance and their implications for international cooperation, including rising climate concerns, economic volatility, and increasing great power tensions amid a global pandemic. The Council of Councils (CoC) is an international initiative created by the Council on Foreign Relations to connect leading foreign policy institutes from around the world in a dialogue on issues of global governance and multilateral cooperation. The CoC is composed of twenty-eight major policy institutes from some of the world’s most influential countries. It is designed to facilitate candid, not-for-attribution dialogue and consensus-building among influential opinion leaders from both established and emerging nations, with the ultimate purpose of injecting the conclusions of its deliberations into high-level foreign policy circles within members' countries.
  • COVID-19
    Latin America’s Vaccination Efforts: What to Know
    Campaigns to vaccinate Latin America against COVID-19 have sparked debate about the region’s dependence on outside suppliers, including China and Russia, and the threat of new variants.
  • Public Health Threats and Pandemics
    A Virtual Global Health Summit, Biden and Moon Meet, and More
    Podcast
    Rome hosts the Global Health Summit online, South Korean President Moon Jae-in visits the White House, and the UN Security Council discusses prospects for Syria as the country holds a presidential election.
  • Cybersecurity
    Cyberspace, Digital Technologies, and Reform of Global Health Governance
    A new report provides a window into high-level policy thinking about cyberspace, digital technologies, and the future of global health.
  • Public Health Threats and Pandemics
    2021 Religion and Foreign Policy Workshop
    CFR's annual Religion and Foreign Policy Workshop brings together high-level congregational and lay leaders, scholars of religion, and representatives of faith-based organizations from across the country for conversations on pressing global concerns with policymakers, CFR fellows, and other experts.  The full agenda is available here.
  • Pharmaceuticals and Vaccines
    Good News Emerges About a Malaria Vaccine
    In Africa and elsewhere, COVID-19 dominates media attention. Yet malaria has probably killed four times as many as COVID-19 over the last year in Africa. The disease is caused by a parasite, plasmodium, not a virus or a bacterium. The disease confers no immunity and an individual can catch it repeatedly; in parts of Africa, individuals catch malaria on an annual basis. Europeans had no immunity to malaria, and the disease killed so many that it, in effect, closed West Africa to them. The good news is that early trials of a new vaccine, R21, show an effectiveness rate of 77 percent. Still to be determined is how long the vaccine will be effective. Work on a vaccine against malaria has been underway for years, with remarkably little success. Part of the difficulty is related to the parasitic nature of the disease—parasites are more complex than viruses or bacterium. Part of the answer has been relatively low investment in the search for a vaccine by pharmaceutical companies; the disease mostly affects the poor in lower-income countries. The new vaccine is a further development of Mosquirix, a vaccine with a 56 percent effectiveness after one year, falling to 36 percent after four years. Mosquirix was developed by GlaxoSmithKline in collaboration with the (U.S.) Walter Reed Army Institute of Research and PATH, a nonprofit health organization. To spread, the disease requires an insect vector—a female Anopheles mosquito—and human blood. In humans, the parasite migrates to the liver and from there to the bloodstream. A mosquito can bite an infected human and then spread the disease by biting another human. In adults, the disease is rarely fatal, except among pregnant women and those with weak or compromised immune systems, and the severity of the symptoms decreases as individuals age. Fatalities are primarily among infants and children, not the elderly. Among adults, the disease resembles influenza, with fever, chills, and fatigue. In terms of loss of human participation in the economy, malaria is a huge burden on Africa. Up to now, malaria prevention has been centered on the mosquito: insecticide-treated bed nets are an effective, low-cost intervention, while various prophylactics can also blunt the disease’s progression following infection.
  • South Korea
    United States and South Korea Should Forge “Vaccine Alliance”
    The upcoming South Korea-U.S. summit meeting in Washington, D.C. should serve as an opportunity to forge a symbiotic "vaccine alliance."
  • Public Health Threats and Pandemics
    World Economic Update
    Play
    The World Economic Update highlights the quarter’s most important and emerging trends. Discussions cover changes in the global marketplace with special emphasis on current economic events and their implications for U.S. policy. This series is presented by the Maurice R. Greenberg Center for Geoeconomic Studies and is dedicated to the life and work of the distinguished economist Martin Feldstein.